Home/Filings/5/0001382758-10-000001
5//SEC Filing

Sturtz Laurence E 5

Accession 0001382758-10-000001

CIK 0001004724other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 11:33 AM ET

Size

21.3 KB

Accession

0001382758-10-000001

Insider Transaction Report

Form 5
Period: 2009-12-31
Transactions
  • Award

    Common Stock

    2009-12-07+8,76839,350 total
  • Small Acquisition

    Common Stock

    2009-12-31+3,76239,350 total
  • Award

    Warrants

    2009-12-078,76845,152 total
    From: 2012-11-16Exp: 2017-11-16Common Stock (8,768 underlying)
Holdings
  • Common Stock

    39,350
  • Warrants

    Exercise: $2.50From: 2006-11-07Exp: 2014-12-08Common Stock (4,000 underlying)
    45,152
  • Options

    Exercise: $2.50From: 2005-06-01Exp: 2010-06-01Common Stock (8,000 underlying)
    15,000
  • Options

    Exercise: $1.50From: 2009-05-09Exp: 2014-05-09Common Stock (1,400 underlying)
    15,000
  • Options

    Exercise: $1.50From: 2010-05-09Exp: 2015-05-09Common Stock (1,400 underlying)
    15,000
  • Options

    Exercise: $1.50From: 2011-05-09Exp: 2016-05-09Common Stock (1,400 underlying)
    15,000
  • Warrants

    Exp: 2017-11-16Common Stock (35,072 underlying)
    45,152
  • Options

    Exercise: $1.50From: 2007-05-09Exp: 2012-05-09Common Stock (1,400 underlying)
    15,000
  • Options

    Exercise: $1.50From: 2008-05-09Exp: 2013-05-09Common Stock (1,400 underlying)
    15,000
Footnotes (5)
  • [F1]On August 15, 2008 the shareholders approved an incentive plan which granted warrants to certain officers and directors. The warrants vested over a five year period. On December 7, 2009 the shareholders approved an amendment to the incentive plan to eliminate 218,461 warrants. The amendment further called for 218,461 shares of the Company's common stock with a one year restriction on transfer to be issued.
  • [F2]The exercise price of the warrants vested in 2008 was $1.21 per share, those vested in 2009 was $2.25, those vested in 2010 was $3.00 and those vesting in 2011 is $4.00 per share.
  • [F3]The exercise price of the warrants was based upon the average closing price of the Company's common stock on NYSE-Amex during January 2011 but not less than $3.00.
  • [F4]On December 21, 2009 the warrant holders voted to amend the warrant agreement to decrease the exercise price from $5.40 to $2.50 and to extend the expiration date to 12/8/2014 the fifth anniversary date of the Company's private offering.
  • [F5]Shares were purchased throughout 2009 at various prices by particiation in the AdCare Health Systems Employee Stock Purchase Program.

Issuer

ADCARE HEALTH SYSTEMS INC

CIK 0001004724

Entity typeother

Related Parties

1
  • filerCIK 0001382758

Filing Metadata

Form type
5
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 11:33 AM ET
Size
21.3 KB